News on research and diagnostic development for pathogenic diseases.
The British Columbia Centre for Disease Control will use genomic analysis to identify the origins and spread of SARS-CoV-2, formerly known as 2019-nCoV.
The two organizations are collaborating to perform a standardized evaluation of currently available molecular diagnostic tests to assess test performance.
The funding comes from the Bill and Melinda Gates Foundation, which previously provided the company with $500,000 for the test's initial development.
The firm saw strong increases in international HIV sales of its OraQuick HIV Self-Test product in the quarter.
The plan piggybacks on national influenza surveillance, testing flu-negative samples using the CDC's rRT-PCR test for the novel coronavirus.
